187 related articles for article (PubMed ID: 37042843)
1. Clearing the fog: A closer look at the differences between axial psoriatic arthritis and axial spondyloarthritis.
Benavent D; Navarro-Compán V
ARP Rheumatol; 2023; 2(1):3-6. PubMed ID: 37042843
[No Abstract] [Full Text] [Related]
2. Axial spondyloarthritis and psoriatic arthritis: mostly overlapping or substantially different diseases?
Braun J; Coates LC
RMD Open; 2023 May; 9(2):. PubMed ID: 37208031
[No Abstract] [Full Text] [Related]
3. Similarities and differences between axial spondyloarthritis and axial psoriatic arthritis.
Wang W; Lee YH; Wei JC; Mease P
Int J Rheum Dis; 2023 Mar; 26(3):407-409. PubMed ID: 36645129
[No Abstract] [Full Text] [Related]
4. Same, same or different? Commonalities and differences between spondyloarthritis and its subsets of axial and peripheral spondyloarthritis with psoriatic arthritis and its diverse phenotypes.
Proft F; Käding H
RMD Open; 2023 Apr; 9(2):. PubMed ID: 37028815
[No Abstract] [Full Text] [Related]
5. Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?'.
Gladman DD; Mease PJ; Bird P; Soriano ER; Chakravarty SD; Shawi M; Lavie F; Gong C; Leibowitz E; Poddubnyy D; Tam LS; Helliwell PS; Kavanaugh A; Deodhar AA; Østergaard M; Baraliakos X
Ann Rheum Dis; 2023 Aug; 82(8):e187. PubMed ID: 35487679
[No Abstract] [Full Text] [Related]
6. Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?'.
Siebert S; Marzo-Ortega H
Ann Rheum Dis; 2023 Aug; 82(8):e185. PubMed ID: 34844925
[No Abstract] [Full Text] [Related]
7. [Axial spondyloarthritis and psoriatic arthritis : Current results and assessments].
Braun J
Z Rheumatol; 2020 Feb; 79(1):1-4. PubMed ID: 32040748
[No Abstract] [Full Text] [Related]
8. Response to: Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?' by Gladman.
Landewé RB; Braun J
Ann Rheum Dis; 2023 Aug; 82(8):e188. PubMed ID: 35487678
[No Abstract] [Full Text] [Related]
9. Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy.
Mease PJ
Rheum Dis Clin North Am; 2022 May; 48(2):507-521. PubMed ID: 35400375
[TBL] [Abstract][Full Text] [Related]
10. Response to: Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physicianreported spondylitis'?' by Siebert and Marzo-Ortega.
Braun J; Landewé RB
Ann Rheum Dis; 2023 Aug; 82(8):e186. PubMed ID: 34844931
[No Abstract] [Full Text] [Related]
11. Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis.
Kleinert S; Schuch F; Rapp P; Ronneberger M; Wendler J; Sternad P; Popp F; Bartz-Bazzanella P; von der Decken C; Karberg K; Gauler G; Wurth P; Späthling-Mestekemper S; Kuhn C; Englbrecht M; Vorbrüggen W; Adler G; Welcker M
Rheumatol Int; 2023 Jan; 43(1):89-97. PubMed ID: 36441274
[TBL] [Abstract][Full Text] [Related]
12. Axial Psoriatic Arthritis: A Distinct Clinical Entity in Search of a Definition.
Michelena X; Poddubnyy D; Marzo-Ortega H
Rheum Dis Clin North Am; 2020 May; 46(2):327-341. PubMed ID: 32340705
[TBL] [Abstract][Full Text] [Related]
13. Axial psoriatic arthritis: New entity or clinical form only?
Wendling D; Verhoeven F; Claudepierre P; Goupille P; Pham T; Prati C
Joint Bone Spine; 2022 Oct; 89(5):105409. PubMed ID: 35577051
[No Abstract] [Full Text] [Related]
14. Disease activity measurements and monitoring in psoriatic arthritis and axial spondyloarthritis.
Machado PM; Raychaudhuri SP
Best Pract Res Clin Rheumatol; 2014 Oct; 28(5):711-28. PubMed ID: 25488780
[TBL] [Abstract][Full Text] [Related]
15. Spondyloarthritides.
Taitt HA; Balakrishnan R
Immunol Allergy Clin North Am; 2023 Aug; 43(3):593-612. PubMed ID: 37394262
[TBL] [Abstract][Full Text] [Related]
16. No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?
Braun J; Landewé RB
Ann Rheum Dis; 2022 Apr; 81(4):466-468. PubMed ID: 34656991
[TBL] [Abstract][Full Text] [Related]
17. Active Disease in Psoriatic Arthritis: An Assessment of Spondyloarthritis International Society Health Index (ASAS-HI)-based Analysis.
Queiro R; Morante I; Braña I
J Rheumatol; 2022 Aug; 49(8):961-963. PubMed ID: 35649552
[No Abstract] [Full Text] [Related]
18. IL-23 in axial spondyloarthritis and psoriatic arthritis: a good fit for biological treatment?
Atzeni F; Siragusano C; Masala IF; Antonio C; Valentina P; D'Angelo S
Expert Opin Biol Ther; 2022 Jul; 22(7):843-853. PubMed ID: 35722768
[TBL] [Abstract][Full Text] [Related]
19. Ankylosing Spondylitis - Axial Spondyloarthritis (2nd ed.).
D'Angelo S
Clin Exp Rheumatol; 2022 Sep; 40(9):1816. PubMed ID: 36129798
[No Abstract] [Full Text] [Related]
20. [Spondyloarthritis: new names for old acquaintances].
van der Horst-Bruinsma IE
Ned Tijdschr Geneeskd; 2014; 158():A7820. PubMed ID: 25351383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
